177Lu-DOTATATE Shows Promising Efficacy in the Treatment of Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas By Ogkologos - September 2, 2025 281 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the Phase II study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate ESMO and ASCO publish joint consensus statement on streamlining clinical research FDA Grants Accelerated Approval to Camizestrant with a CDK4/6 Inhibitor for ESR1-Mutated HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer MOST POPULAR Foodie Friday: Watermelon Fruit Pizza September 3, 2021 Disguising Cancer as an Infection Helps the Immune System Eliminate Tumors July 22, 2022 Common anti-inflammatory drug could boost cancer immunotherapy May 26, 2021 Group of Breast Cancer Survivors is Finding New Strength from Fitness... May 11, 2021 Load more HOT NEWS FDA Grants Accelerated Approval to the Combination of Avutometinib and Defactinib... Why Wearing Comfortable Clothes During Cancer Treatment Matters Why I Work to Bridge the Gap Between People With Cancer... ASCO20 Virtual Research Round Up Podcast: Central Nervous System Tumors and...
